课题基金 / 基金详情

Modeliing immunity for Biodefense:Enteroagressive E. coli and Helicobacter pylori

Modeliing immunity for Biodefense:Enteroagressive E. coli and Helicobacter pylori
生物防御免疫建模:侵袭性大肠杆菌和幽门螺杆菌
批准号:
9119579
负责人:
Josep Bassaganya-Riera
金额:
$150.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2016-07-28

项目摘要

项目成果

Josep Bassaganya-Riera的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Modeling Immunity for Biodefense Program supports research to create new or improved mathematical models that are able to generate knowledge from standard or complex datasets and guide further experimentation to advance the study of immunology or immune-based therapies. The program also supports accompanying immunological experimentation to provide the data required for model development and testing. Specifically, the scope of activities includes: ¿ Development and refinement of mathematical and computational models to be used for knowledge discovery through integration and analysis of complex and/or standard datasets. ¿ Assessment of model functionality thought the iterative process, requiring the acquisition of quantitative immunological measurement for developing, testing, validating, and refining the computational models. ¿ Establishment of a bioinformatics component to maintain a database of immunological data and develop immune modeling tools. ¿ Development of an educational component consisting of summer school programs and symposia for the broader research community to promote the use of mathematical and computational modeling in studies of immune responses to infection or immune-based therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel first-in-class Therapeutics for Rheumatoid Arthritis
  • 批准号:
    10696749
  • 项目类别:
  • 资助金额:
    $29.59万
  • 财政年份:
    2023
  • 负责人:
    Josep Bassaganya-Riera
  • 依托单位:
Targeting the Immunometabolic Hub Nlrx1 as a Novel Therapeutic for Asthma
  • 批准号:
    10323994
  • 项目类别:
  • 资助金额:
    $36.15万
  • 财政年份:
    2021
  • 负责人:
    Josep Bassaganya-Riera
  • 依托单位:
The First Abscisic Acid-Containing Medical Food for Glycemic Control
  • 批准号:
    9199816
  • 项目类别:
  • 资助金额:
    $25.0万
  • 财政年份:
    2016
  • 负责人:
    Josep Bassaganya-Riera
  • 依托单位:
Development of Novel LANCL2-based Anti-diabetic Compounds
  • 批准号:
    8644667
  • 项目类别:
  • 资助金额:
    $18.83万
  • 财政年份:
    2013
  • 负责人:
    Josep Bassaganya-Riera
  • 依托单位:
海外基金